Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

Last Close
Feb 11 02:07PM ET
25.72
Dollar change
-0.32
Percentage change
-1.21
%
CategoryUS Equities - Industry Sector Asset TypeEquities (Stocks) TagsGlobal Return% 1Y4.98% Shs Outstand Perf Week-1.88%
SponsorFidelity ETF Type Tagsequity Return% 3Y- Total Holdings62 Perf Month1.93%
Fund Family Bond Type Tagstechnology Return% 5Y- AUM55.35M Perf Quarter-1.95%
Index- Average Maturity Tagsmedical Return% 10Y NAV% Perf Half Y4.09%
Index Weighting Commodity Type Tagsdisruptive Return% SI NAV/sh Perf Year3.09%
Active/Passive Quant Type Tagsinnovation Flows% 1M0.00% 52W Range23.32 - 26.79 Perf YTD4.30%
Dividend TTM0.11 (0.44%) ESG Type Tags- Flows% 3M0.00% 52W High-3.99% Beta1.22
Dividend Ex-DateDec 20, 2024 Dividend Type Sector/Theme Flows% YTD0.00% 52W Low10.29% ATR (14)0.33
Expense0.50% Structure Type Region Flows% 1Y RSI (14)46.28 Volatility0.73% 1.01%
Option/ShortNo / Yes Growth/Value Dev/Emerg Flows% 3Y Rel Volume0.78 Prev Close26.03
Inverse/Leveraged Market Cap Currency Flows% 5Y Avg Volume5.35K Price25.72
SMA20-1.13% SMA50-0.05% SMA2001.98% Trades Volume3,174 Change-1.21%
Fidelity Disruptive Medicine ETF seeks long-term growth of capital. The fund normally invests at least 80% of assets in securities of disruptive medicine companies. Fidelity's disruptive strategies seek to identify innovative developments that could signal new directions for delivering products and services to customers. Generally, these companies have or are developing new or unconventional ways of doing business that could disrupt and displace incumbents over time. The fund is non-diversified.